Mon, March 25, 2024
Fri, March 22, 2024
Thu, March 21, 2024
Wed, March 20, 2024
Tue, March 19, 2024

Kalpit Patel Maintained (VRDN) at Strong Buy with Decreased Target to $25 on, Mar 21st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-25-on-mar-21st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Kalpit Patel of B. Riley Securities, Maintained "Viridian Therapeutics, Inc." (VRDN) at Strong Buy with Decreased Target from $29 to $25 on, Mar 21st, 2024.

Kalpit has made no other calls on VRDN in the last 4 months.



There are 5 other peers that have a rating on VRDN. Out of the 5 peers that are also analyzing VRDN, 0 agree with Kalpit's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Kalpit


  • Serge Belanger of "Needham" Maintained at Strong Buy and Held Target at $30 on, Wednesday, March 20th, 2024
  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $37 on, Thursday, February 29th, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $40 on, Wednesday, February 28th, 2024
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $36 on, Tuesday, December 19th, 2023
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Thursday, December 14th, 2023

Publication Contributing Sources